Even if their trial is a success, a Mom and Pop pharmaceutical operations like Jacobus has no capacity whatsoever to manufacture 3,4-Dap to all LEMS population. They should stick to supplying Dapsone to Lepers IMO.
"I also don't expect a new CEO as we may already have suitor(s) lined up and negotiating."
They have to announce a new CEO first even if it's just for formality. Otherwise, we have to wait until Harvey retires in December because that's the deal.
What's going on here?
On the other hand, laterloretta posted above pretty much guarantees that she will keep the stocks and options afterall.
Seem so sudden and unexpected. I think she got ousted. Common sense dictates that if it's her choice, she would have opted to stay for atleast one year to keep her stock and options.
Company is shady. Their plan is to keep buying these shell companies that they already own at shareholders expense. They started with Bralorne and there are 7 more I think.
Lol. Now I wonder how many times they did a reverse split to come to this price?